LeonaBio, Inc. (LONA) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

LeonaBio, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

LeonaBio, Inc. (LONA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 50.24 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14

• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 45.56M shares, a 4289.36% increase year-over-year.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.04M shares, a 89.99% decline year-over-year.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 10.37M shares, a 49.13% increase year-over-year.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.96M shares, a 83.64% increase year-over-year.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 51.06M shares, a 4884.78% increase from fiscal 2024.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.02M shares, a 85.64% decline from fiscal 2023.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.13M shares, a 66.89% increase from fiscal 2022.
• LeonaBio, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.28M shares, a 62.32% increase from fiscal 2021.